/ / A. Thyroid and other radiation-related diseases in the exposed and comparison populations. B. All of A plus other patients already taken into the study with non-radiation related diseases (e.g., diabetes}. This would include exposed and comparison group patients only. C. All of A and B plus all low level radiation exposed patients who have gone through full screening, irrespective of findings of disease (e.g., the Bikini group). D. on, All of A, B, and C plus full screening of all inhabitants living or scheduled to be repatriated to, atomic fallout; the Marshall Istinds contaminated by i.e., background radiation higher than median for all Micronesian islands. * E. Discontinue the study under DOE mandate and turn the care over to the new Marshall Island Health Care System. * With these five options in mind, we must first consider the common constraints impinging on the subheadings listed under Column II of the flow sheet (see Figure 1}. priate. The unique constraints for each option will be listed as appro- The common constraints are: 1. Under current operating policies, DOE responsibilities do not include health care for non-irradiation related pathologic conditions. 2. not clear. The defin:-ion of "radiation-related"” pathologic conditions is There is uncertainty among radiation experts as to the biologic ef- fects of long-term "low-level" radiation. The status ~* acute and long-term ef- fects of higher levels of radiation offers a greater consensus by the experts. ORT ree ete a